Once wide coercive powers are given to government agencies…such powers cannot be effectively controlled. F.A. Hayek As part of the chorus calling for drug price controls, the New York Times editorial page has claimed that “America...
07 November, 2019
PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes discusses 2020 Democratic contender Sen. Elizabeth Warren’s plan to provide a public health care system with host Elizabeth MacDonald on ...
31 October, 2019
Sally C. Pipes debates against the replacement of private insurance for Medicare for all at Intelligence Squared Debates in New York. Intelligence Squared Debates is non-partisan debate series that brings together experts to discu...
18 September, 2019Biosimilars have the opportunity to bring significant savings to state Medicaid programs and consumers with commercial insurance according to a new study released today by Pacific Research Institute. “Every state would experience ...
02 October, 2019Biosimilars have the potential to realize billions in savings for the health care system if reforms are enacted to incent their market share to grow, according to a new issue brief issued today by the Center for Medical Economics ...
11 July, 2019Much-Publicized Report on Financial Returns on Cancer Treatments Contains Significant Flaws and Biases, Finds New Center for Medical Economics and Innovation Brief New PRI Brief Finds WHO Report Overstates Returns by 350 Percent...
12 June, 2019One issue that was pushed on the backburner in this year’s very eventful legislative session was single-payer health care. Surprisingly, even though the Senate actually passed a single payer bill (SB 562) last session, a single-pa...
07 October, 2019Recently, I had a health scare that sent me to the emergency room for a few hours. The care that I received at UC Davis Medical Center was excellent. I drove myself to the emergency room at 6:30 in the morning. Upon registering,...
20 August, 2019SAN FRANCISCO – A new poll from the California-based nonpartisan think tank, the Pacific Research Institute (PRI), shows that Americans overwhelmingly support innovative gene therapies, which change the focus of medicine from trea...
26 June, 2019Wayne Winegarden, Director for PRI’s Center for Medical Economics and Innovation, discusses the many problems with drug price controls on the nationally syndicated Jim Bohannon Show....
13 November, 2019Listen to Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, discuss his recent Forbes op-ed on prescription drug price controls and how they would threaten access to innovative cures for America’...
01 November, 2019
PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes discusses 2020 Democratic contender Sen. Elizabeth Warren’s plan to provide a public health care system with host Elizabeth MacDonald on ...
31 October, 2019
Commentary
How Big-Box Retailers Can Revitalize Rural Health Care
There’s a surefire, and perhaps unlikely, way to bolster access to health care for underserved Americans—at the shopping mall. Millions of Americans struggle to get affordable, timely medical care. Roughly one-quarter of rur...
14 November, 2019A dose of reality on Medicare for All’s cost
Presidential hopeful Elizabeth Warren just released her plan to pay for Medicare for All. It’s ludicrous from the jump. For starters, its price tag is “only” $20.5 trillion in new federal spending over 10 years. ...
11 November, 2019There Are High Costs From Implementing Drug Price Controls
Once wide coercive powers are given to government agencies…such powers cannot be effectively controlled. F.A. Hayek As part of the chorus calling for drug price controls, the New York Times editorial page has claimed that “America...
07 November, 2019